Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Changes to rebate structure of Medicare Part D program
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EISAI INC. via EISAI INC.
2019 · second_quarter · 2T
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Proposed HHS rule on Rebates
Regulatory and legislative health care issues impacting pricing and access * Regulatory and legislative health care issues, including the 340B program * Issues related to diagnosis and treatment of Alzheimer's Disease * FDA Guidance on Alzheimer's Drug Development
Source: Senate LDA
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Proposed HHS rule on Rebates
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Changes to rebate structure of Medicare Part D program
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Proposed HHS rule on Rebates
HR 1625 Consolidated Appropriations Act of 2018 -- Inclusion of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions Changes to reimbursement structure of Medicare Part D program H.R. 1892 Bipartisan Budget Act of 2018
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions Changes to reimbursement structure of Medicare Part D program H.R. 1892 Bipartisan Budget Act of 2018
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program Changes to coverage policy for certain drugs in the Medicare Part D program Proposed Part B International Pricing Index Demonstration program
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing Issues related to the diagnosis and treatment of Alzheimer's Disease
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing Issues related to the diagnosis and treatment of Alzheimer's Disease
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program Changes to coverage policy for certain drugs in the Medicare Part D program Proposed Part B International Pricing Index Demonstration program
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions Changes to reimbursement structure of Medicare Part D program H.R. 1892 Bipartisan Budget Act of 2018
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing Issues related to the diagnosis and treatment of Alzheimer's Disease
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: EISAI INC. · Firm: EISAI INC.
HR 1 Tax Cut and Jobs Act -- Issues related to corporate tax reform
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Legislation to amend the Affordable Care Act - Addressing pricing and access issues, prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs
National Defense Authorization Act for Fiscal Year 2018
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs in general and in the following legislation: H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
National Defense Authorization Act for Fiscal Year 2018
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
National Defense Authorization Act for Fiscal Year 2018
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs in general and in the following legislation: H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program
Providing for consideration of the concurrent resolution (S. Con. Res. 3) setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026, and providing for consideration of the bill (S. 84) to provide for an exception to a limitation against appointment of persons as Secretary of Defense within seven years of relief from active duty as a regular commissioned officer of the Armed Forces.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Providing for consideration of the concurrent resolution (S. Con. Res. 3) setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026, and providing for consideration of the bill (S. 84) to provide for an exception to a limitation against appointment of persons as Secretary of Defense within seven years of relief from active duty as a regular commissioned officer of the Armed Forces.
Client: EISAI INC. · Firm: EISAI INC.
prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Providing for consideration of the concurrent resolution (S. Con. Res. 3) setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026, and providing for consideration of the bill (S. 84) to provide for an exception to a limitation against appointment of persons as Secretary of Defense within seven years of relief from active duty as a regular commissioned officer of the Armed Forces.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Providing for consideration of the concurrent resolution (S. Con. Res. 3) setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026, and providing for consideration of the bill (S. 84) to provide for an exception to a limitation against appointment of persons as Secretary of Defense within seven years of relief from active duty as a regular commissioned officer of the Armed Forces.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act - Addressing pricing and access issues, prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: EISAI INC. · Firm: EISAI INC.
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act - Addressing pricing and access issues, prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Establishing the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2017 and setting for the appropriate budgetary levels for fiscal years 2018 through 2026.
Establishing the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Establishing the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 Revisions to Medicare Part B Payment policies
National Defense Authorization Act for Fiscal Year 2017
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
National Defense Authorization Act for Fiscal Year 2017
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
National Defense Authorization Act for Fiscal Year 2017
Client: EISAI INC. · Firm: EISAI INC.
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR 4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR 4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Client: EISAI INC. · Firm: EISAI INC.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Legislative discussions related to issues of health care pricing, value and outcomes. Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Chronic Disease Initiative Senate HELP Innovation Project
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Finance Committee Chronic Care Work Group Initiative Senate HELP Innovations Project Centers for Medicare and Medicaid Innovation demonstration programs
Legislative discussions related to issues of health care pricing, value and outcomes. Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Chronic Disease Initiative Senate HELP Innovation Project
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Finance Committee Chronic Care Work Group Initiative Senate HELP Innovations Project Centers for Medicare and Medicaid Innovation demonstration programs
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via EISAI INC.
2019 · first_quarter · Q1
Ongoing discussions and updates on Helsinn v. Teva
Regulatory and legislative health care issues impacting pricing and access * Regulatory and legislative health care issues, including the 340B program * Issues related to diagnosis and treatment of Alzheimer's Disease * FDA Guidance on Alzheimer's Drug Development
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Changes to rebate structure of Medicare Part D program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via EISAI INC.
2018 · fourth_quarter · Q4
Ongoing discussions and updates Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries, Ltd.
Regulatory and legislative health care issues impacting pricing and access Implementation of Chronic Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to diagnosis and treatment of obesity Issues related to the diagnosis and treatment of Alzheimer's Disease FDA Guidance on Alzheimer's Disease Drug Development
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program Changes to coverage policy for certain drugs in the Medicare Part D program Proposed Part B International Pricing Index Demonstration program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via EISAI INC.
2018 · third_quarter · Q3
Regulatory and legislative health care issues impacting pricing and access Implementation of P.L. 115-176 Trickett Wendler, Frank Mongiello, Jordan McLinn and Matthew Bellina Right to Try Act of 2017 Implementation of Chronic Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to diagnosis and treatment of obesity Drug Cost and Pricing Issues related to the diagnosis and treatment of Alzheimer's Disease FDA Guidance on Alzheimer's Disease Drug Development
Ongoing discussions and updates on Amicus petition for certiori in Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries, Ltd.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs to cover obesity products Changes to reimbursement structure of Medicare Part D program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via EISAI INC.
2018 · second_quarter · Q2
Ongoing discussions and updates on Amicus petition for certiori in Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries, Ltd.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions Changes to reimbursement structure of Medicare Part D program H.R. 1892 Bipartisan Budget Act of 2018
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing Issues related to the diagnosis and treatment of Alzheimer's Disease
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI INC. via EISAI INC.
2018 · first_quarter · Q1
HR 1625 Consolidated Appropriations Act of 2018 -- Inclusion of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Amicus petition for certiori in Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries, Ltd.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
EISAI INC. via EISAI INC.
2017 · third_quarter · 3A
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
DoD/TRICARE coverage of FDA-approved obesity drugs in general and in the following legislation: H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
EISAI INC. via EISAI INC.
2017 · fourth_quarter · Q4
HR 1 Tax Cut and Jobs Act -- Issues related to corporate tax reform
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
EISAI INC. via EISAI INC.
2017 · third_quarter · Q3
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
EISAI INC. via EISAI INC.
2017 · second_quarter · Q2
Issues related to corporate tax reform
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program
EISAI INC. via EISAI INC.
2017 · first_quarter · Q1
Legislation to amend the Affordable Care Act - Addressing pricing and access issues, prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. Treat and Reduce Obesity Act of 2017 (Bills not introduced 1Q17) Revisions to Medicare reimbursement programs
EISAI INC. via EISAI INC.
2016 · fourth_quarter · Q4
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Finance Committee Chronic Care Work Group Initiative Senate HELP Innovations Project Centers for Medicare and Medicaid Innovation demonstration programs
EISAI INC. via EISAI INC.
2016 · third_quarter · Q3
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Finance Committee Chronic Care Work Group Initiative Senate HELP Innovations Project Centers for Medicare and Medicaid Innovation demonstration programs
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
EISAI INC. via EISAI INC.
2016 · second_quarter · Q2
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR 4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
Legislative discussions related to issues of health care pricing, value and outcomes. Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Chronic Disease Initiative Senate HELP Innovation Project
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
EISAI INC. via EISAI INC.
2016 · first_quarter · Q1
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res ___ - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. S Con Res ___ - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2017 and setting for the appropriate budgetary levels for fiscal years 2018 through 2026.
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR ____/S ____) Department of Defense Appropriations Bill for 2017 (HR ____/S ____)
EISAI INC. via EISAI INC.
2015 · second_quarter · 2A
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
DEA scheduling of controlled substances H.R. 639/S 481 - Improving Regulatory Transparency for New Medical Therapies Act
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR 1735/S 1376) Department of Defense Appropriations Bill for 2016 (HR 2685/S 1558)
EISAI INC. via EISAI INC.
2015 · fourth_quarter · Q4
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Chronic Disease Initiative Senate HELP Innovation Project
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR 1735/S 1376) Department of Defense Appropriations Bill for 2016 (HR 2685/S 1558)
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
EISAI INC. via EISAI INC.
2015 · third_quarter · Q3
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025.
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
EISAI INC. via EISAI INC.
2015 · second_quarter · Q2
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR 1735/S 1376) Department of Defense Appropriations Bill for 2016 (HR 2685/S 1558)
EISAI INC. via EISAI INC.
2015 · first_quarter · Q1
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. ____/S. ____ - Treat and Reduce Obesity Act of 2015
Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR ____/S ____) Department of Defense Appropriations Bill for 2016 (HR ____/S ____)
EISAI INC. via EISAI INC.
2014 · fourth_quarter · Q4
DoD/TRICARE coverage of FDA-approved obesity medications H.R. 4435/S. 2410 -- National Defense Authorization bill for 2015 H.R. 4870 -- Department of Defense Appropriations Bill for 2015 (including H.R. 83 - Consolidated and Further Continuing Appropriations Act of FY15)
H.R. 3890/S. 1932 -- Better Care, Lower Cost Act Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54
DEA Scheduling of Controlled Substances H.R. 4299 -- Improving Regulatory Transparency for New Medical Therapies Act S. 2862 -- Transparency, Patient Access and Effective Drug Enforcement Act of 2014
EISAI INC. via EISAI INC.
2014 · third_quarter · Q3
* EXPIRE Act of 2014 - S. 2260; Issues related to tax reform
* Treat and Reduce Obesity Act of 2013 - HR 2415/S 1184; Medicare coverage of FDA-approved obesity medications * Improving Regulatory Transparency for New Medical Therapies Act - HR 4299; Improvement of DEA scheduling process * Commerce, Justice, Science and Related Agencies Appropriations Act of 2015 - HR 4660/S 2437; Drug Enforcement Administration (DEA) issues * Medicare Patient Access and Qulaity Improvement Act of 2013 - HR 2810
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusions of Medicare coverage of obesity Rx products * FY2014 Omnibus - HR 3547 * FY2014 Continuing Resolution - HJRes 106; PL 113-73 * FY2014 Continuing Resolution - HJRes 59; PL 113-67 * HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - PL 113-93
EISAI INC. via EISAI INC.
2014 · second_quarter · Q2
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products * FY 2014 Omnibus - HR 3547 * FY 2014 Continuing Resolution HJRes 106; PL 113-73 * FY 2014 Continuing Resolution HJRes 59; PL 113-67 * HR 4302 SGR Patch Protecting Access to Medicare Act of 2014: PL 113-93 * HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 - Medicare coverage of FDA-approved obesity medications
DoD/TRICARE coverage of obesity drugs * National Defense Authorization Bill for 2015 (HR 4435/S 2410) * Department of Defense Appropriations Bill for 2015 (HR 4870/S _____)
S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Filing targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Regulatory and legislative health care issues impacting pricing and access in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Issues related to corporate tax reform
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
Filing targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
DoD/TRICARE coverage of FDA-approved obesity drugs in general and in the following legislation: H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
Legislation to amend the Affordable Care Act -- Addressing pricing and access issues, prescription drug importation, potential reimbursement changes prescription drug importation, potential reimbursement changes in the following legislation: H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation.
Issues related to corporate tax reform
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs
DoD/TRICARE coverage of FDA-approved obesity drugs H.R. 2810/S. ____ - National Defense Authorization Act for Fiscal Year 2018
prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate tax reform
Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2018 (Bills not formally introduced as of filing)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 Revisions to Medicare Part B Payment policies
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2017 and setting for the appropriate budgetary levels for fiscal years 2018 through 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative discussions related to issues of health care pricing, value and outcomes. Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Chronic Disease Initiative Senate HELP Innovation Project
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025.
Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
DEA scheduling of controlled substances H.R. 639/S 481 - Improving Regulatory Transparency for New Medical Therapies Act (PL 114-89)
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025. Bipartisan Budget Act of 2015 (PL 114-74) - Various health and tax issues Consolidated Appropriations Act (PL 114-113) - Various health and tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act
DEA scheduling of controlled substances H.R. 639/S 481 - Improving Regulatory Transparency for New Medical Therapies Act
DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR 1735/S 1376) Department of Defense Appropriations Bill for 2016 (HR 2685/S 1558)
IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEA scheduling of controlled substances H.R. 639/S 481 - Improving Regulatory Transparency for New Medical Therapies Act
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025.
DEA scheduling of controlled substances H.R. 639/S. 481 - Improving Regulatory Transparency for New Medical Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4870 -- Department of Defense Appropriations Act of 2015 -- DoD/TRICARE Issues HJ Res 124 -- Continuing Appropriations Resolution 2015 - DoD/TRICARE Issues, Medicare Issues (pharmaceutical reimbursement offsets, coverage of obesity Rx products) H.R. 83 -- Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235) -- Included FY 15 DoD Appropriations (DoD/TRICARE coverage of obesity drugs)
H.R. 2415/S. 1184 -- Treat and Reduce Obesity Act of 2013 -- Medicare Part D H.R. 2810 -- Medicare Patient Access and Quality Improvement Act of 2013 -- Medicare Part B and D patient access and choice H.R. 4302 Protecting Access to Medicare Act of 2014 (SGR Patch) - P.L. 113-93 -- Medicare Part B Patient Access
S. 2260 -- EXPIRE Act of 2014 -- Issues Related to Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage for FDA-approved obesity Rx products * FY2014 Omnibus - HR 3547 * FY2014 Continuing Resolution - HJRes 106; PL 113-73 * FY2014 Continuing Resolution - HJRes 59; PL 113-67 * SGR Patch Protecting Access to Medicare Act of 2014 - HR 4302; PL 113-93 * Treat and Reduce Obesity Act of 2013 - HR 2415/S 1184; Medicare coverage of FDA-approved obesity medications
DoD/TRICARE coverage of FDA-approved obesity medications * National Defense Authorization Bill for 2015 (HR 4435/S 2410) * Department of Defense Appropriations Bill for 2015 (HR 4870/S ____)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 2260, EXPIRE Act of 2014 -- issues related to tax reform
HR 2415/S 1184 - Treat and Reduce Obesity Act of 2013 - Medicare coverage of obesity medications HR 4299 - Improving Regulatory Transparency for New MEdical Therapies Act -- DEA scheduling process HR 4660/S 2437 - Commerce, Justice, Science, and Related Agencies Appropriations Act of 2015; Drug Enforcement Administration (DEA) issues HR 2810 - Medicare Patient Access and Quality Improvement Act of 2013
Potential pharmaceutical reimbursement cuts (offsets), potential inclusion of Medicare coverage of obesity Rx products * FY 2014 Omnibus - HR 3547 * FY 2014 Continuing Resolution HJRes 106 - PL 113-73 * FY 2014 Continuing Resolution HJRes 59 - PL 113-67 * HR 4302 SGR Patch Protecting Access to MEdicare Act of 2014 - PL 113-93
Filing targets: HOUSE OF REPRESENTATIVES, SENATE